Lipiodol Ultra Fluide (Ethyl Esters Of Iodised Fatty Acids From Poppyseed Oil)

The ethyl esters contain a high concentration of iodine bound to fatty‑acid chains, making the solution radiopaque. After intra‑arterial or intralymphatic injection, the oily droplets remain in the vascular or lymphatic spaces, providing sustained contrast that enhances X‑ray or CT visualization of vessels and lesions.

The dose is determined by the prescribing physician based on the specific imaging study, the vascular territory, and patient factors. The amount administered is calculated to achieve adequate radiopacity while minimizing exposure, and it is delivered under imaging guidance by a qualified radiologist or interventionalist.

Safety data in pregnant or lactating women are limited, and the product is classified as contraindicated unless clearly necessary. Iodine can cross the placenta and enter breast milk, potentially affecting fetal or infant thyroid function, so use only after careful risk‑benefit assessment by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Unlike water‑soluble agents, Lipiodol Ultra Fluide is oil‑based, providing prolonged retention in vascular and lymphatic spaces and higher radiopacity for certain embolization procedures. However, it may have a higher risk of oil embolism and requires careful handling, whereas water‑soluble agents are cleared more rapidly and are generally used for routine angiography.

Lipiodol Ultra Fluide should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. It must be protected from direct sunlight, moisture and extreme temperature fluctuations. The product should not be frozen, and any opened vial should be used promptly according to the manufacturer’s stability guidelines.

The product is supplied as a sterile liquid for intra‑arterial or intralymphatic injection. Administration is performed by a qualified radiologist or interventional specialist under imaging guidance, using appropriate catheters or needles. The volume injected is tailored to the imaging objective, and the procedure is conducted in a setting equipped for monitoring of vital signs and potential adverse reactions.

The most serious risks include severe allergic reactions such as anaphylaxis, oil embolism leading to pulmonary or systemic compromise, and acute kidney injury in patients with pre‑existing renal impairment. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after the procedure.

Patients with known hypersensitivity to iodine‑containing contrast media, a history of severe allergic reactions, uncontrolled thyroid disease, or severe renal insufficiency should generally avoid Lipiodol Ultra Fluide. Additionally, it is contraindicated in pregnant women unless the diagnostic benefit outweighs the potential risk to the fetus, and in individuals where oil‑based embolic agents are contraindicated.